
Overview
Biofarm is one of Poland’s largest pharmaceutical companies, based in Poznan and producing medicines, dietary supplements and preparations for pharmacy and non-pharmacy markets. The company operates its own Research and Development Centre, has 180 registered products, and manufactures more than 93% of its medicines at its Poznan production facility.
Financials
Revenue history (in m)
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.
From the notes
| Current income tax (CIT due) | $8,278,732 | |
| Profit allocation | Dividend and reserves | |
| R&D costs | $543,826 | |
| Management board pay | $336,702 | |
| Parent company | Biofarm Sp. z o.o. | |
| Shares in other companies |
|
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 87 days late). All were audited by a statutory auditor.
- 202507/07/2026
- 202403/07/2025
- 202312/07/2024
- 202211/07/2023
- 202110/10/2022
- 202023/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Websites
The company has 4 websites. Most of them run on WordPress. The sites are available in: Polish, English and Ukrainian. The sites target these markets: United States and Ukraine. Traffic on the sites is measured with Google Analytics.
- biofarm.plBiofarm | Producent leków, firma farmaceutyczna z PoznaniaGoogle AnalyticsGoogle Tag ManagerApache
- actigraforte.plStrona główna – ActiGra ForteWordPress 7.1Yoast SEOApache
- cemaxforte.plCemax Forte Biofarm – suplement dietyWordPress 7.1ElementorGoogle Tag ManagerApache
Public procurement
No recorded participation in tenders.
The company is the contractor in one public sector contract, worth USD 1.41k.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Jul 22, 2026 | Medication donation | $1,413 | Wojewódzki Szpital Zdrowia Psychicznego Im. Dr. Józefa Bednarza w Świeciu |
Trademarks
The company holds 317 active trademarks registered with the Polish Patent Office. 8 applications are pending. 512 marks have expired or were not registered. The first mark was filed in 1991.
| Mark | Protected until | |
|---|---|---|
| Aciviran (word) | Mar 5, 2036 | |
| Gliforin (word) | Feb 24, 2036 | |
| Novelio (word) | Jan 27, 2036 | |
| Fenalid Duo (word) | Jan 27, 2036 | |
| Nevellia (word) | Jan 27, 2036 |
Job offers
The company has its own careers page: biofarm.pl/kariera.
Authorized Representatives
Manner of representation
If the company’s management board is a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations and sign on behalf of the company.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 1,201 | $590,443.00 | 36.3939% | |
| 1,499 | $736,947.60 | 45.4242% | |
Others | 600 | $294,975.69 | 18.1819% |
Waldemar Jarosław Szwarczyński and Grażyna Małgorzata Denkowska Szwarczyńska hold a combined 81.8% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Biofarm - Hurt sp. z o.o. | 86,925.99 USD | 99.9689% |
Bank accounts
Registered as a VAT taxpayer on 1996-01-03.
18 1750 1019 0000 0000 0222 3635
86 1240 1747 1978 0010 0076 4846
80 1750 1019 0000 0000 0373 3197
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 1.2MPLN 1,214,660 |
Investment property | PLN 509.5KPLN 509,464 |
Secured liabilities
| Type | Secures | |
|---|---|---|
Registered pledge over a machine | Loans in the form of overdraft facilities | |
Registered pledge over inventory | Loans in the form of overdraft facilities |
MSiG notices
| Publication date | Event | |
|---|---|---|
| May 10, 2017 | Return of additional payments |
Public aid
9 public aid cases recorded, with a total value of $1,355,210.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 29, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $15,900$15,900 | DGA S.A. | |
| Mar 25, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $17,329$17,329 | DGA S.A. | |
| Oct 7, 2019 | Regional investment aid | $78,969$78,969 | Minister Funduszy i Polityki Regionalnej |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| Waste generation | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Adamed Pharma S.A. | $541,927,181.76 | adamed.com.pl | ||
| Aflofarm Farmacja Polska sp. z o.o. | $302,019,142.07 | aflofarm.pl | ||
| Zentiva Polska sp. z o.o. | $134,295,523.17 | zentiva.pl | ||
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A. | $119,621,017.71 | hasco-lek.pl | ||
| Farmak International sp. z o.o. | $101,647,142.16 | farmakinternational.pl | ||
| Synoptis Pharma sp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| Polfarmex S.A. | $73,543,379.32 | polfarmex.pl | ||
| SUN-Farm sp. z o.o. | $51,063,341.52 | sunfarm.pl | ||
| Poznańskie Zakłady Zielarskie Herbapol S.A. | $31,668,225.77 | herbapol.poznan.pl | ||
| Tactica Pharmaceuticals sp. z o.o. | $28,095,609.42 | tactica.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-04-05 | Share capital increase (6,000,000.00 PLN → 6,006,000.00 PLN) | |
| 2015-08-19 | Share capital increase (60,000.00 PLN → 6,000,000.00 PLN) | |
| 2002-07-15 | Entered in the register |
FAQ
Last updated: 2026-10-07